GOP Lawmakers Seek FTC Scrutiny Of Drug Benefit Managers
Republicans on the House Energy & Commerce Committee asked the Federal Trade Commission on Friday to examine how consolidation among pharmacy benefit managers has affected drug prices, adding to fast-rising scrutiny...To view the full article, register now.
Already a subscriber? Click here to view full article